TY - JOUR
T1 - Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndrome
AU - Van Houten, Pepijn
AU - Netea-Maier, Romana
AU - Wagenmakers, Margreet
AU - Roerink, Sean
AU - Hermus, Ad
AU - Van de Ven, Annenienke
N1 - Publisher Copyright:
© 2021 BioScientifica Ltd.. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - Objective: Cushing's syndrome (CS) is associated with osteoporosis and hi gh fracture risk. Besides male sex, it is unknown which variables influence bone mineral density (BMD) at diagnosis and it is unclear to what extent BMD normalizes during long-term follow-up after treatment of CS . The aim of this study was to determine factors associated with BMD at diagnosis of CS and to determine the lon g-term course of BMD and fracture rate after successful treatment of CS. Design: Retrospective cross-sectional and longitudinal cohort study. Methods: Data were collected from 231 patients with CS who were treated at the Radboud University Medical Centre between 1968 and 2020. Results: At diagnosis, male sex was associated with lower Z-scores at th e lumbar spine (LS) compared with female sex: -0.97s.d. (-1.45 to -0.49) after correction for possible confounders. Shorter durati on of symptoms and younger age were also associated with lower Z-scores at diagnosis, while et iology of CS, urinary cortisol excretion and gonadal status were not associated with Z-scores at diagnosis. Z-scores improved up to 20 years after treatment. Fifteen years after treatment, men showed larger improvements of Z-scores tha n women; +2.56 (1.82-3.30) increase in LS Z-score vs +1.48 (0.96-2.00) respectively. Fracture incidence was highest during the 2 years before diagnosis and decreased after treatment. Conclusion: Male sex, younger age and shorter duration of symptoms are ass ociated with lower BMD at diagnosis of CS. BMD continues to improve up to 20 years after treatment of CS. Fracture rate decreases after treatment of CS.
AB - Objective: Cushing's syndrome (CS) is associated with osteoporosis and hi gh fracture risk. Besides male sex, it is unknown which variables influence bone mineral density (BMD) at diagnosis and it is unclear to what extent BMD normalizes during long-term follow-up after treatment of CS . The aim of this study was to determine factors associated with BMD at diagnosis of CS and to determine the lon g-term course of BMD and fracture rate after successful treatment of CS. Design: Retrospective cross-sectional and longitudinal cohort study. Methods: Data were collected from 231 patients with CS who were treated at the Radboud University Medical Centre between 1968 and 2020. Results: At diagnosis, male sex was associated with lower Z-scores at th e lumbar spine (LS) compared with female sex: -0.97s.d. (-1.45 to -0.49) after correction for possible confounders. Shorter durati on of symptoms and younger age were also associated with lower Z-scores at diagnosis, while et iology of CS, urinary cortisol excretion and gonadal status were not associated with Z-scores at diagnosis. Z-scores improved up to 20 years after treatment. Fifteen years after treatment, men showed larger improvements of Z-scores tha n women; +2.56 (1.82-3.30) increase in LS Z-score vs +1.48 (0.96-2.00) respectively. Fracture incidence was highest during the 2 years before diagnosis and decreased after treatment. Conclusion: Male sex, younger age and shorter duration of symptoms are ass ociated with lower BMD at diagnosis of CS. BMD continues to improve up to 20 years after treatment of CS. Fracture rate decreases after treatment of CS.
UR - http://www.scopus.com/inward/record.url?scp=85110348459&partnerID=8YFLogxK
U2 - 10.1530/EJE-21-0226
DO - 10.1530/EJE-21-0226
M3 - Article
C2 - 34061774
AN - SCOPUS:85110348459
SN - 0804-4643
VL - 185
SP - 241
EP - 250
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
IS - 2
ER -